Current and Emerging Applications of cell-free DNA Tumor Tests

Current and Emerging Applications of cell-free DNA Tumor Tests


This webinar is a recorded presentation of a live broadcast and includes a pre-test, the presentation, handout, and a post-test. Continuing education credit is available for the webinar.


This interactive webinar is part 5 of the 8 part Utility of Cell-Free DNA in the Clinic Series.

Description:

Circulating cell-free DNA (cfDNA)-based testing is rapidly becoming an integral part of oncology care.  Technical advances are allowing detection of a range of genomic alterations for diagnosis, prognosis, treatment selection and disease monitoring to support unique patient care needs at different stages of the care cycle. An evidence-based framework is important in evaluating tumor type and biomarker specific evidence for clinical applications. This presentation will include discussion on existing and emerging clinical and technical applications of cfDNA tumor tests. 

Learning Objectives:

1.       Evaluate existing evidence for clinical liquid biopsy applications in oncology.

2.       Discuss emerging applications of ctDNA testing in oncology practices.

3.       Develop strategies to evaluate different genomic alterations using cfDNA.




Speaker:
Keyur Patel, MD, PhD
Moderator:
Marjorie Parker David, MD, MS
Recording Date: March 24, 2022
Duration: 1 hr
Level of Instruction: Basic
CME/CMLE credit: 1.00 hour

Last Day to Claim Credit: December 31, 2023

Physicians (ACCME)           


In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Association for Molecular Pathology.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live to enduring activity for a maximum of 8.00 AMA PRA Category 1 CreditsTM (1.00 CE for each webinar). Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Medical Laboratory Education (CMLE)

This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology as meeting the criteria for up to 8 CMLE credits. ASCP CMLE credits are acceptable to meet the continuing education requirement for the ASCP Board of Registry Certification Maintenance Program.


Note: Join the AMP Family for discounted access to the most current educational resources!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation